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Abstract
The enantioselective synthesis of the carbon skeleton of 6-deoxyerythronolide B has been achieved
in 23 linear steps from propionaldehyde. The synthesis relies on an iterative approach employing an
asymmetric acyl-thiazolidinethione propionate aldol reaction to establish eight of nine stereogenic
centers. The remaining stereogenic center at C6 was set through a Myers alkylation employing a
complex alkyl iodide.
Since their discovery in the 1950’s1 erythromycins have captured the interest of biologists,
synthetic chemists and clinicians alike. Physicians have long valued the antibacterial
properties2 of the family while the synthetic community has been intrigued by challenges
inherent in the strict polypropionate backbone. Biologists, meanwhile, have focused on the
biosynthesis of the various members of the family, and have successfully elucidated the
complete biosynthetic pathway.3
The first isolable (non-enzyme bound) intermediate in the biosynthesis of the erythromycins
is 6-deoxyerythronolide B which was first isolated in 1967 by Martin and Rosenbrook4 from
a blocked mutant of Streptomyces erythreus.5 Three different multi-domain enzymes, the
deoxyerythronolide B synthases, have been shown to be responsible for assembling 6 units of
methylmalonyl CoA and one unit of propionyl CoA in an iterative fashion. As the three
enzymes involved contain 31 distinct domains, nature performs the synthesis of 6-
deoxyerythronolide B in 31 sequential biosynthetic “steps”.6
6-Deoxyerythronolide B has been the subject of substantial synthetic interest, with three total
syntheses having been previously reported.7 Masamune7c and Evans7a each disclosed a
convergent synthesis of 6-deoxyerythronolide B, relying on double diastereoselective aldol
reactions to assemble the polypropionate backbone. By contrast, Danishefsky7b employed a
linear approach to 6-deoxyerythronolide B based on the Lewis acid catalyzed diene aldehyde
condensation to complete the synthesis in 44 linear steps.
Recent reports from our laboratory have described a diastereoselective propionate aldol
reaction based on the use of thiazolidinethione chiral auxiliaries.8 The ease of removal and
facile functional group interconversion of N-acylthiazolidinethiones render this aldol reaction
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of thiazolidinethiones in asymmetric aldol reactions are 1) the use of inexpensive commercial
TiCl4 as the Lewis acid, 2) both syn aldol diastereomers of the aldol adduct can be accessed
from a single antipode of the auxiliary simply by changing the amount and type of base used,
and 3) the thiazolidinethione can be reductively cleaved to the aldehyde with i-Bu2AlH.10,7
Thus, the N -propionylthiazolidinethione allows for a three-step iterative aldol sequence: 1)
diastereoselective aldol addition, 2) protection of the aldol hydroxyl and 3) reduction of the
N-acylthiazolidinethione to an aldehyde.
Inspired by the iterative biosynthesis of 6-deoxyerythronolide B, and intrigued by the possibilty
of performing a synthesis of the natural product using a strictly linear, iterative approach, we
set out to test the applicability of thiazolidinethione aldol reactions in the context of a synthesis
of 6-deoxyerythronolide B.
The accumulated knowledge of the three previous syntheses7 provided a wealth of information
concerning the unique challenge of performing the macrolactonization of the 6-
deoexyerythronolide B backbone and suggested that the Evans seco-acid 4a would be an ideal
substrate to target for a successful synthesis.7a Careful examination of seco-acid 4a, revealed
that all the stereogenic centers could be directly established through syn aldol reactions with
the possible exception of C6. Two potential approaches were envisioned to establish the
requisite stereocenter at C6: a stereoselective hydrogenation or a Myers diastereoselective
alkylation. It was anticipated that both approaches could be investigated through a common
intermediate 11, available from three propionate aldol iterations beginning with
propionaldehyde.
The synthesis of the tetrapropionate 11 commenced with a non-Evans syn aldol reaction
between the N-propionylthiazolidinethione 5 and propionaldehyde. The chlorotitanium enolate
of 5 was formed by addition of 1.05 eq TiCl4, followed by 1.1 eq i-Pr2NEt. Subsequent addition
of propionaldehyde gave alcohol 6 in 91% yield (>20:1 dr). The reaction was readily scalable,
providing reproducible results (both yield and diastereoselectivity) on scales ranging from 1
mmol to over 100 mmol of propionate 5. Exposure of alcohol 6 to TIPSOTf gave the requisite
silyl ether in 96% yield. Reduction of the thioimide with i-Bu2AlH provided aldehyde 7 in
98% yield. The second aldol iteration required the opposite sense of asymmetric induction in
the aldol addition. Thus, aldol reaction of imide 5 with aldehyde 7 was performed by enolization
with 1.0 equiv. TiCl4, 1.0 equiv. (−)-sparteine, and 1.0 equiv. NMP to provide Evans syn aldol
adduct 8 in 96% yield with excellent (>20:1 dr) diastereoselectivity. Alcohol 8 was silylated
by the action of TBSOTf in 95% yield, whereupon reduction of the imide with i-Bu2AlH
provided aldehyde 9 in 93% yield.
The third iteration of the aldol sequence was performed by buffering the chlorotitanium enolate
of thioimide 5 (2.5 eq. i-Pr2NEt) during the reaction with aldehyde 9 to avoid loss or migration
of the C11 silyl ether. The non-Scheme 2 Evans syn aldol adduct 10 was obtained in 98% yield
with excellent selectivity (>20:1 dr). Protection of alcohol 10 as its TES ether provided the
silyl ether 11 in 96% yield.
To examine the diastereoselective hydrogenation to establish the C6 stereocenter, imide 11
was converted to lactone 13. A i-Bu2AlH reduction of imide 11 provided the aldehyde 12, and
a subsequent Still-Gennari11 modified Horner-Wadsworth-Emmons reaction delivered the Z-
enoate. Treatment of the enoate with p-TsOH in methanol removed the silyl ethers and effected
concomitant lactonization to provide the unsaturated lactone 13. Catalytic hydrogenation of
13 proceeded smoothly to provide the desired saturated lactone as a single isomer 14 (structural
proof provided by single crystal X-ray analysis). Interestingly, attempted hydrogenation on
intermediates with the hydroxyl groups protected, for example 15 or 16 and similar variants,
led to very poor conversion, and/or poor selectivity. Due to the protecting group difficulties
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inherent in the hydrogenation approach to set the C6 stereocenter, we turned our attention to
establishing the C6 stereocenter via a Myers alkylation (Scheme 3).12
N-Acylthiazolidinethione 11 was reductively converted to the primary alcohol in 94% yield.
After routine conversion to iodide 17 (85% yield), a Myers alkylation was attempted with
pseudephedrine propionate 1 8 (Scheme 3). Unfortunately, no reaction occurred, even after
extended reaction times and at elevated temperatures. In an attempt to improve the reactivity
of the iodide, the C9 and C11 silyl ethers were replaced with a sterically less demanding cyclic
acetal protecting group, and to allow intersection with Evans seco-acid 4a, a TBS group was
used to protect the C13 hydroxyl.
After substantial experimentation, it was determined that the most effective route to the
required C9-C11 cyclic acetal was to fully deprotect iodide 17 (p-TsOH, MeOH) to obtain the
corresponding triol as a white powder (97% yield) followed by formation of the cyclic PMP
acetal as a mixture of all four possible six-membered acetals. The desired S acetal of the C9-
C11 regioisomer 19 could be easily separated from the mixture, and after equilibration of the
undesired isomers, a 56% yield of acetal 19 was obtained after 3 recycles.
Installation of the requisite TBS group proceeded in 78% yield providing iodide 20. Myers
alkylation of amide 18 with iodide 20 proceeded in 87% yield to provide amide 21 (>98:2 dr).
Removal of the chiral auxiliary in the presence of the acetal was accomplished with lithium
amido trihydroborate in 98% yield.12,13 Dess-Martin oxidation14 of the resulting primary
alcohol provided aldehyde 22 in 86% yield.
The stage was now set for the remaining two iterations of the aldol reaction sequence. An Evans
syn mediated protocol employing excess enolate delivered the desired aldol adduct 23 in 84%
yield (>20:1 dr). Alcohol 23 was masked as the TES ether in 91% yield and reduction of the
N-acylthiazolidinethione provided aldehyde 24 in 98% yield.
The final aldol reaction employed excess enolate under the Evans syn protocol (1.0 equiv.
TiCl4, 1.0 equiv. (−)-sparteine, 1.0 equiv. NMP) and gave alcohol 25 in 77% yield. Completion
of the formal synthesis of 6-deoxyerythronolide B required only protecting group manipulation
and hydrolysis of the auxiliary. Selective deprotection of the TES ether proceeded in 99% yield
by exposure of imide 25 to HF-pyridine buffered with pyridine. The resulting C3-C5 diol was
converted to the acetonide under acidic conditions in 85% yield. Hydrolysis of the auxiliary
by treatment with LiOH provided the acid 4b in 99% yield constituting a formal synthesis of
6-deoxyerythronolide B. Spectral data for synthetic 4b matched the literature values in all
respects.9a
In conclusion, a formal synthesis of 6-deoxyerythronolide B has been achieved in 23 steps and
7.5% overall yield, thus validating the utility of N -acylthiazolidinethiones in an iterative
approach to polypropionates. Aldol additions of thiazolidinethione 5 served to establish 10 of
the 11 stereocenters of 6-deoxyerythronolide B.
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